A global assessment of the inflammatory response elicited upon open abdominal aortic aneurysm repair

Vascular and Endovascular Surgery

Volumn 42, Issue 1, 2008, Pages 47-53

  Vasdekis, Spyros N ^a,d   Argentou, Marianna ^b   Kakisis, John D ^a   Bossios, Apostolos ^c   Gourgiotis, Dimitrios ^c   Karanikolas, Menelaos ^b   Karatzas, Gabriel ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NONE   (Greece)

Author keywords

Abdominal; Aortic aneurysm; Endotoxin; Inflammation; Interleukins; Postoperative period; Tumor necrosis factor

Indexed keywords

CD11 ANTIGEN; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; PERIOPERATIVE PERIOD; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11B; AORTIC ANEURYSM, ABDOMINAL; AREA UNDER CURVE; ENDOTOXINS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38649087928     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574407308942     Document Type: Article

References (54)

1. Katz DJ, Stanley JC, Zelenock GB Operative mortality rates for intact and ruptured abdominal aortic aneurysms in Michigan: an eleven-year statewide experience. J Vasc Surg. 1994 ; 19: 804-815.
2. Baigrie RJ, Lamont PM, Whiting S., Morris PJ Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg. 1993 ; 166: 248-251.
3. Bown MJ, Horsburgh T., Nicholson ML, Bell PR, Sayers RD Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2004 ; 28: 274-280.
4. Swartbol P., Truedsson L., Norgren L. The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2001 ; 21: 393-400.
5. Barry MC, Wang JH, Kelly CJ, Sheehan SJ, Redmond HP, Bouchier-Hayes DJ Plasma factors augment neutrophil and endothelial cell activation during aortic surgery. Eur J Vasc Endovasc Surg. 1997 ; 13: 381-387.
6. Davies MG, Fulton GJ, Hagen PO Clinical biology of nitric oxide. Br J Surg. 1995 ; 82: 1598-1610.
7. Novitsky TJ Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci. 1998 ; 851: 416-421.
8. Moore FA The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg. 1999 ; 178: 449-453.
9. Marshall JC, Christou NV, Meakins JL The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg. 1993 ; 218: 111-119.
10. Yassin MM, Barros D. ' Sa AA, Parks TG, et al. Lower limb ischaemia-reperfusion injury alters gastrointestinal structure and function. Br J Surg. 1997 ; 84: 1425-1429.
11. Yassin MM, Barros D. ' Sa AA, Parks G., Abdulkadir AS, Halliday I., Rowlands B. Mortality following lower limb ischemia-reperfusion: a systemic inflammatory response ? World J Surg. 1996 ; 20: 961-966.
12. Corson RJ, Paterson IS, O'Dwyer ST, et al. Lower limb ischaemia and reperfusion alters gut permeability. Eur J Vasc Surg. 1992 ; 6: 158-163.
13. Ding J., Magnotti LJ, Huang Q., Xu DZ, Condon MR, Deitch EA Hypoxia combined with Escherichia coli produces irreversible gut mucosal injury characterized by increased intestinal cytokine production and DNA degradation. Shock. 2001 ; 16: 189-195.
14. Soong CV, Blair PH, Halliday MI, et al. Bowel ischaemia and organ impairment in elective abdominal aortic aneurysm repair. Br J Surg. 1994 ; 81: 965-968.
15. Yassin MM, Harkin DW, Barros D. ' Sa AA, Halliday MI, Rowlands BJ Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002 ; 26: 115-121.
16. Soong CV, Blair PH, Halliday MI, et al. Endotoxaemia, the generation of the cytokines and their relationship to intramucosal acidosis of the sigmoid colon in elective abdominal aortic aneurysm repair. Eur J Vasc Surg. 1993 ; 7: 534-539.
17. Cabie A., Farkas JC, Fitting C., et al. High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine. 1993 ; 5: 448-453.
18. Roumen RM, Hendriks T., van der Ven-Jongekrijg J., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993 ; 218: 769-776.
19. Froon AH, Greve JW, Van der Linden CJ, Buurman WA Increased concentrations of cytokines and adhesion molecules in patients after repair of abdominal aortic aneurysm. Eur J Surg. 1996 ; 162: 287-296.
20. Thompson MM, Nasim A., Sayers RD, et al. Oxygen free radical and cytokine generation during endovascular and conventional aneurysm repair. Eur J Vasc Endovasc Surg. 1996 ; 12: 70-75.
21. Parsson HN, Nassberger L., Norgren L. Inflammatory response to aorto-bifemoral graft surgery. Int Angiol. 1997 ; 16: 55-64.
22. Barry MC, Kelly C., Burke P., Sheehan S., Redmond HP, Bouchier-Hayes D. Immunological and physiological responses to aortic surgery: effect of reperfusion on neutrophil and monocyte activation and pulmonary function. Br J Surg. 1997 ; 84: 513-519.
23. Groeneveld AB, Raijmakers PG, Rauwerda JA, Hack CE The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function. Eur J Vasc Endovasc Surg. 1997 ; 14: 351-359.
24. Syk I., Brunkwall J., Ivancev K., et al. Postoperative fever, bowel ischaemia and cytokine response to abdominal aortic aneurysm repair-a comparison between endovascular and open surgery. Eur J Vasc Endovasc Surg. 1998 ; 15: 398-405.
25. Swartbol P., Norgren L., Albrechtsson U., et al. Biological responses differ considerably between endovascular and conventional aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 1996 ; 12: 18-25.
26. Norgren L., Albrechtsson U., Swartbol P. Side-effect of endovascular grafting to treat aortic aneurysm. Br J Surg. 1996 ; 83: 520-521.
27. Swartbol P., Parsson H., Truedsson L., Sjoholm A., Norgren L. Aortobifemoral surgery induces complement activation and release of interleukin-6 but not tumour necrosis factor-alpha. Cardiovasc Surg. 1996 ; 4: 483-491.
28. Raijmakers PG, Groeneveld AB, Rauwerda JA, et al. Transient increase in interleukin-8 and pulmonary microvascular permeability following aortic surgery. Am J Respir Crit Care Med. 1995 ; 151: 698-705.
29. Galle C., De Maertelaer, V., Motte S., et al. Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery. J Vasc Surg. 2000 ; 32: 234-246.
30. Morikage N., Esato K., Zenpo N., Fujioka K., Takenaka H. Is endovascular treatment of abdominal aortic aneurysms less invasive regarding the biological responses ? Surg Today. 2000 ; 30: 142-146.
31. Hill GE, Mihalakakos PJ, Spurzem JR, Baxter TB Supraceliac, but not infrarenal, aortic cross-clamping upregulates neutrophil integrin CD11b. J Cardiothorac Vasc Anesth. 1995 ; 9: 515-518.
32. Welborn MB, Oldenburg HS, Hess PJ, et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med. 2000 ; 28: 3191-3197.
33. Kim PK, Deutschman CS Inflammatory responses and mediators. Surg Clin North Am. 2000 ; 80: 885-894.
34. Norwood MG, Bown MJ, Sutton AJ, Nicholson ML, Sayers RD Interleukin 6 production during abdominal aortic aneurysm repair arises from the gastrointestinal tract and not the legs. Br J Surg. 2004 ; 91: 1153-1156.
35. Adembri C., Kastamoniti E., Bertolozzi I., et al. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med. 2004 ; 32: 1170-1177.
36. Raijmakers PG, Groeneveld AB, Rauwerda JA, Teule GJ, Hack CE Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111 indium-labelled transferrin and circulating mediators. Thorax. 1997 ; 52: 866-871.
37. Panza JA Endothelial dysfunction in essential hypertension. Clin Cardiol. 1997 ; 20: 26-33.
38. Wilcox JN, Subramanian RR, Sundell CL, et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997 ; 17: 2479-2488.
39. Feron O., Dessy C., Moniotte S., Desager JP, Balligand JL Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest. 1999 ; 103: 897-905.
40. Blair A., Shaul PW, Yuhanna IS, Conrad PA, Smart EJ Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem. 1999 ; 274: 32512-32519.
41. Kuhlencordt PJ, Gyurko R., Han F., et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001 ; 104: 448-454.
42. Arnal JF, Dinh-Xuan AT, Pueyo M., Darblade B., Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci. 1999 ; 55: 1078-1087.
43. Oyadomari S., Gotoh T., Aoyagi K., Araki E., Shichiri M., Mori M. Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide. 2001 ; 5: 252-260.
44. Duplain H., Burcelin R., Sartori C., et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001 ; 104: 342-345.
45. Kurz S., Harrison DG Insulin and the arginine paradox. J Clin Invest. 1997 ; 99: 369-370.
46. Watanabe G., Tomiyama H., Doba N. Effects of oral administration of L-arginine on renal function in patients with heart failure. J Hypertens. 2000 ; 18: 229-234.
47. Harrison DG Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997 ; 100: 2153-2157.
48. Granger DN Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation. 1999 ; 6: 167-178.
49. Harris NR Reperfusion-induced changes in capillary perfusion and filtration: effects of hypercholesterolemia. Am J Physiol. 1999 ; 277: H669 - H675.
50. Steinberg HO, Bayazeed B., Hook G., Johnson A., Cronin J., Baron AD Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation. 1997 ; 96: 3287-3293.
51. Kurose I., Wolf RE, Grisham MB, Granger DN Hypercholesterolemia enhances oxidant production in mesenteric venules exposed to ischemia/reperfusion. Arterioscler Thromb Vasc Biol. 1998 ; 18: 1583-1588.
52. Salas A., Panes J., Elizalde JI, Granger DN, Pique JM Reperfusion-induced oxidative stress in diabetes: cellular and enzymatic sources. J Leukoc Biol. 1999 ; 66: 59-66.
53. Panes J., Kurose I., Rodriguez-Vaca D., et al. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation. 1996 ; 93: 161-167.
54. Salas A., Panes J., Elizalde JI, et al. Mechanisms responsible for enhanced inflammatory response to ischemia-reperfusion in diabetes. Am J Physiol. 1998 ; 275: H1773 - H1781.